HELENS (09869) announced that shareholders approved a general and unconditional mandate for the board to repurchase up to 10% of the total issued shares (approximately 127 million shares) as of the annual general meeting date on May 14, 2025. This authorization will expire upon the earliest of: (i) the conclusion of the next annual general meeting in 2026, (ii) the deadline for holding the next annual general meeting as required by the company's articles of association or applicable laws, or (iii) the date shareholders revoke or amend the authorization via an ordinary resolution.

On November 6, 2025, the board resolved to exercise the share repurchase authorization, planning to buy back shares in the open market using existing internal financial resources. The company believes the current trading price does not fully reflect its intrinsic value. The repurchase demonstrates HELENS' long-term confidence in its growth prospects and financial health, aiming to enhance net asset value and earnings per share, aligning with the best interests of the company and shareholders.